2021
DOI: 10.1111/cts.13129
|View full text |Cite
|
Sign up to set email alerts
|

How can real‐world evidence aid decision making during the life cycle of nonprescription medicines?

Abstract: is an employee of Bayer Consumer Healthcare o Christelle Anquez-Traxler is an employee of AESGP, the Association of the European Self-Care Industry, which represents the manufacturers of nonprescription medicinal products, self-care medical devices and food supplements in Europe. The association is funded by member companies and national member associations' fees. o Matthew J Francis is an employee of The Procter & Gamble Company o Larry Ma is an employee of Johnson & Johnson o Denise Teotico Pohlhaus is an em… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 11 publications
(8 citation statements)
references
References 45 publications
0
7
0
Order By: Relevance
“…HBB [ 7 , 9 , 18 , 19 , 20 , 21 , 22 , 23 , 24 ], PLUS [ 9 ] and PO [ 8 , 25 ] have proven effectiveness in controlled trials, compared with a placebo for each of them. However, based on the trial setting and on the inclusion and exclusion criteria such randomized, controlled trials are not helpful to reflect real-world conditions in OTC settings where they are inherently dispensed without the involvement of a prescribing physician [ 26 ]. On the other hand, PBPS are established tools in the evaluation of OTC products and were used in real-world trials in various indications including functional bowel disorders [ 10 ], headache and migraine [ 11 , 14 , 27 ], or cough and cold [ 12 , 13 ].…”
Section: Discussionmentioning
confidence: 99%
“…HBB [ 7 , 9 , 18 , 19 , 20 , 21 , 22 , 23 , 24 ], PLUS [ 9 ] and PO [ 8 , 25 ] have proven effectiveness in controlled trials, compared with a placebo for each of them. However, based on the trial setting and on the inclusion and exclusion criteria such randomized, controlled trials are not helpful to reflect real-world conditions in OTC settings where they are inherently dispensed without the involvement of a prescribing physician [ 26 ]. On the other hand, PBPS are established tools in the evaluation of OTC products and were used in real-world trials in various indications including functional bowel disorders [ 10 ], headache and migraine [ 11 , 14 , 27 ], or cough and cold [ 12 , 13 ].…”
Section: Discussionmentioning
confidence: 99%
“…Opportunities for real-world studies include the validation of OTC drug safety and efficacy, monitoring real world outcomes, and examination of when/why consumers purchase and use these products; consequently, such studies may have a powerful impact on decision-making surrounding non-prescription medicines. 53 …”
Section: Discussionmentioning
confidence: 99%
“…HBB (7,9,(18)(19)(20)(21)(22)(23)(24), PLUS (9) and PO (8,25) have proven effectiveness in controlled trials as compared to placebo for each of them. However, based on the trial setting and on the inclusion and exclusion criteria such randomized, controlled trials are not helpful to reflect the real-world in OTC settings where they are inherently dispensed without involvement of a prescribing physician (26). On the other hand, PBPS are established tools in the evaluation of OTC products and were used in real-world trials in various indications including functional bowel disorders (10), headache and migraine (11,14,27) or cough & cold (12,13).…”
Section: Critique Of Methodsmentioning
confidence: 99%